Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
filingDate |
1996-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47ff64c64be400d9de11fa40ef1a2596 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2f56d3467fc27a69a42130a6ccc9cfb |
publicationDate |
1998-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H107590-A |
titleOfInvention |
Therapeutic agent for cerebral circulation disorder sequela or cerebral neuropathy after cerebral ischemia |
abstract |
(57) [Summary] [Objective] To provide an agent for treating or preventing sequelae of cerebral circulation disorder or cranial nerve disorder after cerebral ischemia. An agent for treating or preventing sequelae of cerebral circulation disorder such as cerebral vascular dementia or cerebral neuropathy after cerebral ischemia, comprising a compound selected from non-steroidal anti-inflammatory compounds as an active ingredient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03024457-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8580818-B2 |
priorityDate |
1996-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |